Berlin - Delayed Quote EUR

Bristol-Myers Squibb Co (BRM.BE)

41.42
+0.74
+(1.82%)
As of 8:00:27 AM GMT+2. Market Open.
Advanced Chart
Loading Chart for BRM.BE
  • Previous Close 40.68
  • Open 41.42
  • Bid 41.21 x --
  • Ask 41.54 x --
  • Day's Range 41.42 - 41.42
  • 52 Week Range 36.60 - 58.11
  • Volume 0
  • Avg. Volume 9
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jul 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: BRM.BE

View More
View More

Performance Overview: BRM.BE

Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BRM.BE
23.14%
S&P 500 (^GSPC)
1.30%

1-Year Return

BRM.BE
6.90%
S&P 500 (^GSPC)
12.35%

3-Year Return

BRM.BE
34.54%
S&P 500 (^GSPC)
52.75%

5-Year Return

BRM.BE
13.56%
S&P 500 (^GSPC)
103.85%

Compare To: BRM.BE

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

BRM.BE
Bristol-Myers Squibb Co
41.42
+1.82%
Mkt Cap EUR -
Industry Drug Manufacturers—General
PFIZER.NS
Pfizer Limited
4,457.20
+1.00%
Mkt Cap INR 203.907B
Industry Drug Manufacturers—General
NOV.DE
Novo Nordisk A/S
57.93
+1.61%
Mkt Cap EUR 258.138B
Industry Drug Manufacturers—General
NVS
Novartis AG
109.59
+1.04%
Mkt Cap 216.45B
Industry Drug Manufacturers—General
BAYN.DE
Bayer Aktiengesellschaft
22.99
+0.52%
Mkt Cap EUR 22.586B
Industry Drug Manufacturers—General
GILD
Gilead Sciences, Inc.
102.50
+2.15%
Mkt Cap 127.503B
Industry Drug Manufacturers—General
MRK
Merck & Co., Inc.
76.06
+1.68%
Mkt Cap 190.989B
Industry Drug Manufacturers—General
PFE
Pfizer Inc.
22.83
+1.02%
Mkt Cap 129.797B
Industry Drug Manufacturers—General
ABBV
AbbVie Inc.
184.02
+1.29%
Mkt Cap 325.053B
Industry Drug Manufacturers—General
NVO
Novo Nordisk A/S
64.37
-2.69%
Mkt Cap 284.344B
Industry Drug Manufacturers—General
LLY
Eli Lilly and Company
757.39
+3.50%
Mkt Cap 679.936B
Industry Drug Manufacturers—General

Statistics: BRM.BE

View More

Valuation Measures

Annual
As of 5/16/2025

  • Market Cap

    85.00B

  • Enterprise Value

    120.25B

  • Trailing P/E

    16.99

  • Forward P/E

    6.68

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.94

  • Price/Book (mrq)

    5.33

  • Enterprise Value/Revenue

    2.83

  • Enterprise Value/EBITDA

    8.31

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: BRM.BE

View More
View More

Company Insights: BRM.BE

Research Reports: BRM.BE

View More
View More

People Also Watch

BRM.SG Bristol-Myers Squibb Co
41.52
-0.40%
 
BRM.F Bristol-Myers Squibb Company
41.10
-0.98%
 
BRM.DU Bristol-Myers Squibb Co
41.47
-0.53%
 
BRM.DE Bristol-Myers Squibb Company
41.44
-0.42%
 
BMYS.VI Bristol-Myers Squibb Company
41.53
-0.16%
 
0R1F.IL Bristol-Myers Squibb Company
46.55
+0.98%
 
NOTA.SG Novartis AG
97.00
+0.41%
 
BRM.MU Bristol-Myers Squibb Co
41.42
+1.82%
 
SNW2.F Sanofi
46.00
+1.32%
 
0QLR.IL Novartis AG
91.38
+0.45%
 
RHO6.F Roche Holding AG
34.80
+0.42%
 
BRM.HM Bristol-Myers Squibb Co
41.51
0.00%
 
0A2V.IL Sanofi
51.32
0.00%
 
NOTA.F Novartis AG
95.20
-0.63%
 
CHV.BE Chevron Corp
124.86
-1.16%
 
MRCK34.SA Merck & Co., Inc.
54.37
+1.46%